Publications

BibTex format

@inproceedings{Mcneish:2018,
author = {Mcneish, IA and Lin, KK and Radke, MR and Oza, AM and Oaknin, A and Ray-Coquard, I and Tinker, AV and Helman, E and Isaacson, J and Maloney, L and O'malley, DM and Chambers, SK and Kaufmann, SH and Scott, C and Konecny, GE and Coleman, RL and Giordano, H and Brenton, JD and Harding, TC and Swisher, EM},
pages = {E28--E28},
publisher = {ELSEVIER SCI LTD},
title = {BRCA reversion mutations in circulating cell-free tumour DNA predict primary and acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma (HGOC)},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461258600054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2018}
}

Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Mcneish,IA
AU  - Lin,KK
AU  - Radke,MR
AU  - Oza,AM
AU  - Oaknin,A
AU  - Ray-Coquard,I
AU  - Tinker,AV
AU  - Helman,E
AU  - Isaacson,J
AU  - Maloney,L
AU  - O'malley,DM
AU  - Chambers,SK
AU  - Kaufmann,SH
AU  - Scott,C
AU  - Konecny,GE
AU  - Coleman,RL
AU  - Giordano,H
AU  - Brenton,JD
AU  - Harding,TC
AU  - Swisher,EM
EP  - 28
PB  - ELSEVIER SCI LTD
PY  - 2018///
SN  - 0959-8049
SP  - 28
TI  - BRCA reversion mutations in circulating cell-free tumour DNA predict primary and acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma (HGOC)
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461258600054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -

Download

ProfessorIainMcNeish

Contact

Assistant

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)